Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents, Phytogenic | 3 | 2020 | 134 | 1.670 |
Why?
|
| Chemokine CCL2 | 4 | 2022 | 95 | 1.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2023 | 968 | 1.330 |
Why?
|
| Gossypol | 2 | 2020 | 6 | 1.260 |
Why?
|
| Apoptosis | 9 | 2024 | 1568 | 1.210 |
Why?
|
| Cell Proliferation | 12 | 2023 | 1455 | 1.180 |
Why?
|
| Flavonoids | 3 | 2025 | 100 | 1.150 |
Why?
|
| Naphthoquinones | 2 | 2018 | 41 | 1.070 |
Why?
|
| Cell Line, Tumor | 14 | 2024 | 2676 | 0.900 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2025 | 92 | 0.890 |
Why?
|
| Osteoporosis | 1 | 2025 | 45 | 0.870 |
Why?
|
| 3T3-L1 Cells | 1 | 2024 | 18 | 0.860 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 1019 | 0.860 |
Why?
|
| Anti-Obesity Agents | 1 | 2024 | 11 | 0.850 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2020 | 161 | 0.850 |
Why?
|
| Vitis | 1 | 2024 | 37 | 0.830 |
Why?
|
| Adipocytes | 1 | 2024 | 60 | 0.820 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 299 | 0.730 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 1723 | 0.690 |
Why?
|
| Iridoids | 1 | 2020 | 5 | 0.680 |
Why?
|
| Plant Extracts | 1 | 2024 | 302 | 0.680 |
Why?
|
| Depsides | 1 | 2020 | 8 | 0.660 |
Why?
|
| Cinnamates | 1 | 2020 | 7 | 0.660 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2023 | 384 | 0.640 |
Why?
|
| Interleukin-8 | 1 | 2020 | 74 | 0.640 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 133 | 0.630 |
Why?
|
| Cell Cycle | 2 | 2021 | 346 | 0.620 |
Why?
|
| NF-kappa B | 2 | 2022 | 358 | 0.610 |
Why?
|
| Contraceptive Agents, Male | 1 | 2019 | 4 | 0.610 |
Why?
|
| Aging | 1 | 2025 | 783 | 0.600 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 291 | 0.540 |
Why?
|
| Obesity | 1 | 2024 | 1151 | 0.470 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 187 | 0.460 |
Why?
|
| Microglia | 1 | 2017 | 208 | 0.460 |
Why?
|
| Cytokines | 2 | 2021 | 678 | 0.440 |
Why?
|
| Humans | 23 | 2025 | 43102 | 0.420 |
Why?
|
| Benzophenanthridines | 2 | 2023 | 14 | 0.390 |
Why?
|
| Isoquinolines | 2 | 2023 | 55 | 0.380 |
Why?
|
| Signal Transduction | 5 | 2023 | 2157 | 0.370 |
Why?
|
| Allyl Compounds | 2 | 2024 | 55 | 0.370 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1070 | 0.370 |
Why?
|
| Antioxidants | 3 | 2025 | 443 | 0.360 |
Why?
|
| Cell Survival | 4 | 2021 | 945 | 0.300 |
Why?
|
| Female | 11 | 2024 | 24698 | 0.290 |
Why?
|
| Xanthophylls | 2 | 2023 | 21 | 0.260 |
Why?
|
| Sulfides | 2 | 2024 | 78 | 0.220 |
Why?
|
| Bone Density | 1 | 2025 | 103 | 0.210 |
Why?
|
| Garlic | 1 | 2024 | 31 | 0.210 |
Why?
|
| Anticarcinogenic Agents | 1 | 2024 | 77 | 0.200 |
Why?
|
| Precancerous Conditions | 1 | 2024 | 83 | 0.200 |
Why?
|
| Fruit | 1 | 2024 | 178 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 152 | 0.190 |
Why?
|
| Benzoquinones | 4 | 2023 | 47 | 0.190 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 532 | 0.180 |
Why?
|
| Biological Products | 1 | 2023 | 91 | 0.180 |
Why?
|
| I-kappa B Kinase | 1 | 2022 | 51 | 0.180 |
Why?
|
| Caspase 3 | 2 | 2023 | 227 | 0.180 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 291 | 0.180 |
Why?
|
| Epithelial Cells | 2 | 2024 | 434 | 0.180 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2021 | 40 | 0.170 |
Why?
|
| Cell Movement | 2 | 2022 | 655 | 0.170 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 228 | 0.170 |
Why?
|
| Chemokine CXCL1 | 1 | 2021 | 18 | 0.170 |
Why?
|
| Vimentin | 1 | 2021 | 44 | 0.170 |
Why?
|
| Animals | 3 | 2025 | 16992 | 0.170 |
Why?
|
| Hydrolyzable Tannins | 1 | 2021 | 20 | 0.170 |
Why?
|
| Cell Differentiation | 1 | 2024 | 638 | 0.170 |
Why?
|
| RNA, Messenger | 3 | 2022 | 1271 | 0.170 |
Why?
|
| Antigens, CD | 1 | 2021 | 127 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2020 | 3 | 0.170 |
Why?
|
| Osteoprotegerin | 1 | 2020 | 16 | 0.160 |
Why?
|
| Cadherins | 1 | 2021 | 102 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 159 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 196 | 0.160 |
Why?
|
| Breast | 1 | 2021 | 139 | 0.160 |
Why?
|
| Monoamine Oxidase | 1 | 2020 | 37 | 0.160 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2020 | 28 | 0.160 |
Why?
|
| Mice | 2 | 2024 | 6644 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 216 | 0.150 |
Why?
|
| Chalcones | 1 | 2019 | 17 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2025 | 1003 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 257 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 241 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 508 | 0.140 |
Why?
|
| Paclitaxel | 1 | 2018 | 64 | 0.140 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 95 | 0.130 |
Why?
|
| Lysine | 1 | 2017 | 119 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 128 | 0.130 |
Why?
|
| Quality of Life | 1 | 2022 | 616 | 0.130 |
Why?
|
| Mutation | 1 | 2022 | 1177 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2020 | 561 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 239 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2021 | 518 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2017 | 386 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1124 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2023 | 16 | 0.100 |
Why?
|
| Depression | 1 | 2020 | 863 | 0.100 |
Why?
|
| Benzo(a)pyrene | 2 | 2024 | 128 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 1092 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2022 | 456 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2022 | 536 | 0.080 |
Why?
|
| Middle Aged | 1 | 2022 | 12222 | 0.060 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2023 | 4 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2024 | 52 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2023 | 5 | 0.050 |
Why?
|
| Carotenoids | 1 | 2023 | 74 | 0.050 |
Why?
|
| Chemokines | 1 | 2023 | 96 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 183 | 0.050 |
Why?
|
| DNA Repair | 1 | 2024 | 198 | 0.050 |
Why?
|
| Glutathione | 1 | 2022 | 171 | 0.040 |
Why?
|
| DNA Polymerase beta | 1 | 2021 | 14 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 190 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 2021 | 25 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 592 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 99 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2020 | 118 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 701 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 695 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 506 | 0.040 |
Why?
|
| Models, Biological | 1 | 2021 | 712 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 758 | 0.030 |
Why?
|
| Male | 1 | 2020 | 23409 | 0.010 |
Why?
|